UniProt ID | PON2_HUMAN | |
---|---|---|
UniProt AC | Q15165 | |
Protein Name | Serum paraoxonase/arylesterase 2 | |
Gene Name | PON2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 354 | |
Subcellular Localization |
Membrane Peripheral membrane protein . |
|
Protein Description | Capable of hydrolyzing lactones and a number of aromatic carboxylic acid esters. Has antioxidant activity. Is not associated with high density lipoprotein. Prevents LDL lipid peroxidation, reverses the oxidation of mildly oxidized LDL, and inhibits the ability of MM-LDL to induce monocyte chemotaxis.. | |
Protein Sequence | MGRLVAVGLLGIALALLGERLLALRNRLKASREVESVDLPHCHLIKGIEAGSEDIDILPNGLAFFSVGLKFPGLHSFAPDKPGGILMMDLKEEKPRARELRISRGFDLASFNPHGISTFIDNDDTVYLFVVNHPEFKNTVEIFKFEEAENSLLHLKTVKHELLPSVNDITAVGPAHFYATNDHYFSDPFLKYLETYLNLHWANVVYYSPNEVKVVAEGFDSANGINISPDDKYIYVADILAHEIHVLEKHTNMNLTQLKVLELDTLVDNLSIDPSSGDIWVGCHPNGQKLFVYDPNNPPSSEVLRIQNILSEKPTVTTVYANNGSVLQGSSVASVYDGKLLIGTLYHRALYCEL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
81 | Ubiquitination | LHSFAPDKPGGILMM HHHCCCCCCCCEEEE | 44.49 | 29967540 | |
91 | 2-Hydroxyisobutyrylation | GILMMDLKEEKPRAR CEEEEECCCCCCCHH | 60.61 | - | |
144 | Ubiquitination | KNTVEIFKFEEAENS CCEEEEEEHHHHHHH | 58.49 | 33845483 | |
147 | Ubiquitination | VEIFKFEEAENSLLH EEEEEHHHHHHHCEE | 65.50 | 29967540 | |
151 | Phosphorylation | KFEEAENSLLHLKTV EHHHHHHHCEEEEHH | 24.66 | 23025827 | |
156 | Ubiquitination | ENSLLHLKTVKHELL HHHCEEEEHHCHHHC | 40.29 | 33845483 | |
159 | Ubiquitination | LLHLKTVKHELLPSV CEEEEHHCHHHCCCC | 36.27 | 29967540 | |
220 | Ubiquitination | KVVAEGFDSANGINI EEEEECCCCCCCCCC | 58.66 | 29967540 | |
227 | Ubiquitination | DSANGINISPDDKYI CCCCCCCCCCCCCEE | 6.29 | 22817900 | |
232 | Ubiquitination | INISPDDKYIYVADI CCCCCCCCEEEHHHH | 40.71 | 29967540 | |
243 | Ubiquitination | VADILAHEIHVLEKH HHHHHHHHHHHHHHC | 29.23 | 22817900 | |
245 | Ubiquitination | DILAHEIHVLEKHTN HHHHHHHHHHHHCCC | 18.35 | 22817900 | |
254 | N-linked_Glycosylation | LEKHTNMNLTQLKVL HHHCCCCCCCEEEEE | 41.84 | 20068230 | |
254 | N-linked_Glycosylation | LEKHTNMNLTQLKVL HHHCCCCCCCEEEEE | 41.84 | 20068230 | |
265 | Phosphorylation | LKVLELDTLVDNLSI EEEEEHHHCEECEEE | 41.11 | 25338102 | |
269 | N-linked_Glycosylation | ELDTLVDNLSIDPSS EHHHCEECEEECCCC | 28.36 | UniProtKB CARBOHYD | |
277 | Ubiquitination | LSIDPSSGDIWVGCH EEECCCCCCEEEEEC | 34.46 | 29967540 | |
289 | Ubiquitination | GCHPNGQKLFVYDPN EECCCCCEEEEECCC | 45.34 | 29967540 | |
301 | Ubiquitination | DPNNPPSSEVLRIQN CCCCCCCHHHHHHHC | 37.18 | 22817900 | |
313 | Ubiquitination | IQNILSEKPTVTTVY HHCHHCCCCEEEEEE | 45.02 | 22817900 | |
323 | N-linked_Glycosylation | VTTVYANNGSVLQGS EEEEECCCCCEECCC | 35.63 | UniProtKB CARBOHYD | |
334 (in isoform 2) | Ubiquitination | - | 21.03 | 21906983 | |
344 | Phosphorylation | DGKLLIGTLYHRALY CCEEEEEEHHHHHHH | 19.70 | 29083192 | |
346 | Phosphorylation | KLLIGTLYHRALYCE EEEEEEHHHHHHHCC | 6.79 | 28152594 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PON2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PON2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PON2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-254, AND MASSSPECTROMETRY. |